Developments in the management of febrile neutropenia.
作者信息
Pascoe J
出版信息
Br J Cancer. 2011 Aug 23;105(5):597-8. doi: 10.1038/bjc.2011.304.
Abstract
摘要
相似文献
1
Developments in the management of febrile neutropenia.
Br J Cancer. 2011 Aug 23;105(5):597-8. doi: 10.1038/bjc.2011.304.
2
Febrile neutropenia: are you up to date?
Can Oncol Nurs J. 2003 Fall;13(4):246-9.
3
[Consensus on management of children with cancer, neutropenia and fever: Update 2008-2009].
Arch Argent Pediatr. 2010 Apr;108(2):e47-70. doi: 10.1590/S0325-00752010000200022.
4
Febrile neutropenia.
BMJ. 2010 Dec 17;341:c6981. doi: 10.1136/bmj.c6981.
5
[Recommendations for Diagnostics and Therapy of Children with Cancer Presenting with Fever and Neutropenia - Comparison of Two Current Guidelines].
Klin Padiatr. 2018 Apr;230(3):115-121. doi: 10.1055/s-0044-101953. Epub 2018 Mar 27.
6
Fever and neutropenia in children with solid tumors is similar in severity and outcome to that in children with leukemia.
Support Care Cancer. 2002 Jan;10(1):58-64. doi: 10.1007/s005200100277.
7
[Fever and cancer: components of diagnosis for optimal management].
Rev Med Interne. 2013 Sep;34(9):545-52. doi: 10.1016/j.revmed.2012.10.368. Epub 2012 Nov 27.
8
[Febrile neutropenia at the emergency department of a cancer hospital].
Rev Med Brux. 2011 Mar-Apr;32(2):74-82.
9
Is it time to redefine the management of febrile neutropenia in cancer patients?
Am J Med. 1995 Mar;98(3):221-3. doi: 10.1016/S0002-9343(99)80366-0.
10
Assessing the Impact of ED Triage Directives on Febrile Oncology Patient Wait Times.
J Emerg Nurs. 2020 Mar;46(2):254-262.e1. doi: 10.1016/j.jen.2019.12.007.
引用本文的文献
1
The time has come for new models in febrile neutropenia: a practical demonstration of the inadequacy of the MASCC score.
Clin Transl Oncol. 2017 Sep;19(9):1084-1090. doi: 10.1007/s12094-017-1644-z. Epub 2017 Mar 13.
本文引用的文献
1
Prognostic evaluation of febrile neutropenia in apparently stable adult cancer patients.
Br J Cancer. 2011 Aug 23;105(5):612-7. doi: 10.1038/bjc.2011.284. Epub 2011 Aug 2.
2
Health-related quality of life anticipated with different management strategies for paediatric febrile neutropaenia.
Br J Cancer. 2011 Aug 23;105(5):606-11. doi: 10.1038/bjc.2011.213. Epub 2011 Jun 21.
3
Cost effectiveness of outpatient treatment for febrile neutropaenia in adult cancer patients.
Br J Cancer. 2011 Apr 26;104(9):1377-83. doi: 10.1038/bjc.2011.101. Epub 2011 Apr 5.
4
Outpatient management of cancer patients with febrile neutropenia: a systematic review and meta-analysis.
Ann Oncol. 2011 Nov;22(11):2358-2365. doi: 10.1093/annonc/mdq745. Epub 2011 Mar 1.
5
Management of febrile neutropenia: ESMO Clinical Practice Guidelines.
Ann Oncol. 2010 May;21 Suppl 5:v252-6. doi: 10.1093/annonc/mdq196.
6
Management of febrile neutropenia in solid tumours and lymphomas using the Multinational Association for Supportive Care in Cancer (MASCC) risk index: feasibility and safety in routine clinical practice.
Support Care Cancer. 2008 May;16(5):485-91. doi: 10.1007/s00520-007-0334-8. Epub 2007 Sep 25.
7
Outpatient oral antibiotics for febrile neutropenic cancer patients using a score predictive for complications.
J Clin Oncol. 2006 Sep 1;24(25):4129-34. doi: 10.1200/JCO.2005.03.9909.
8
Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients.
Cancer. 2006 May 15;106(10):2258-66. doi: 10.1002/cncr.21847.
9
The Multinational Association for Supportive Care in Cancer risk index: A multinational scoring system for identifying low-risk febrile neutropenic cancer patients.
J Clin Oncol. 2000 Aug;18(16):3038-51. doi: 10.1200/JCO.2000.18.16.3038.
Zotero 插件